Scarica l'app Stockscreener
34.07
7.71%
2.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Precedente Chiudi:
$31.63
Aprire:
$31.83
Volume 24 ore:
15.58M
Relative Volume:
3.84
Capitalizzazione di mercato:
$3.80B
Reddito:
-
Utile/perdita netta:
$-99.15M
Rapporto P/E:
-36.63
EPS:
-0.93
Flusso di cassa netto:
$-74.25M
1 W Prestazione:
+11.78%
1M Prestazione:
+3.65%
6M Prestazione:
-47.39%
1 anno Prestazione:
-3.16%
Intervallo 1D:
$31.50
$36.39
Intervallo di 1 settimana:
$28.90
$36.39
Portata 52W:
$28.64
$99.41
Viking Therapeutics Inc Stock (VKTX) Company Profile
Nome
Viking Therapeutics Inc
Settore
Industria
Telefono
858-704-4660
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Confronta VKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
34.07 | 3.80B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-07 | Iniziato | Citigroup | Neutral |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-11-22 | Iniziato | B. Riley Securities | Buy |
| 2024-11-04 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-11 | Iniziato | JP Morgan | Overweight |
| 2024-06-27 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Reiterato | Oppenheimer | Outperform |
| 2024-03-07 | Iniziato | Jefferies | Buy |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2023-05-31 | Ripresa | ROTH MKM | Buy |
| 2023-03-28 | Reiterato | Maxim Group | Buy |
| 2023-03-17 | Iniziato | Stifel | Buy |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Iniziato | BMO Capital Markets | Outperform |
| 2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
| 2020-05-01 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | Oppenheimer | Outperform |
| 2019-06-25 | Iniziato | Stifel | Buy |
| 2019-03-29 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Reiterato | Maxim Group | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Mkt Perform |
| 2018-12-12 | Iniziato | B. Riley FBR | Buy |
| 2018-11-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-18 | Reiterato | Maxim Group | Buy |
| 2018-09-18 | Reiterato | Raymond James | Outperform |
| 2018-07-20 | Iniziato | SunTrust | Buy |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-01 | Reiterato | Laidlaw | Buy |
| 2018-05-31 | Reiterato | Maxim Group | Buy |
| 2018-03-26 | Ripresa | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | Maxim Group | Buy |
| 2017-11-21 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Why Viking Therapeutics Inc. (VKTX) Surged On Friday? - Insider Monkey
Viking Therapeutics jumps amid renewed takeover speculation - MSN
Viking Therapeutics jumps amid renewed takeover speculation (VKTX:NASDAQ) - Seeking Alpha
Why Viking Therapeutics Surged Despite Grim Earnings - Jomfruland.net
Kwani Viking Therapeutics Akwai Tashi Duk Da Mummunan Ribar - Jomfruland.net
(VKTX) Investment Analysis - Stock Traders Daily
Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday? - Yahoo Finance
10 Stocks Stand Strong Amid Cautious Market Environment - Insider Monkey
Why Viking Therapeutics Stock Plummeted by 24% in December - MSN
VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10% - MSN
Viking Therapeutics, Inc. (NASDAQ:VKTX) Sees Large Increase in Short Interest - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.2%Here's What Happened - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Coverage Initiated at Scotiabank - MarketBeat
Scotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform Recommendation - MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Up 3.3%Here's Why - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Up 3.4%Should You Buy? - MarketBeat
Viking Therapeutics Stock Climbs On Q2 EPS Beat - MSN
Mirae Asset Global Investments Co. Ltd. Purchases New Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 3.4%Here's Why - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Hits New 1-Year LowWhat's Next? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.3%Here's What Happened - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.2%Here's Why - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.7%Here's What Happened - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 4.9% on Analyst Downgrade - MarketBeat
Scotiabank Initiates Coverage of Viking Therapeutics (LSE:0VQA) with Sector Outperform Recommendation - Nasdaq
Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.9% After Analyst Downgrade - MarketBeat
Q1 Earnings Forecast for VKTX Issued By HC Wainwright - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.3%Here's What Happened - MarketBeat
3 Weight-Loss Drug Stocks to Watch - Schaeffers Research
Viking Therapeutics (NASDAQ:VKTX) Earns Sector Outperform Rating from Analysts at Scotiabank - MarketBeat
Scotiabank initiated coverage on Viking Therapeutics with a new price target - Quantisnow
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Scotiabank Initiates Viking Therapeutics at Sector Outperform -February 13, 2025 at 07:39 am EST - Marketscreener.com
William Blair Expects Lower Earnings for Viking Therapeutics - MarketBeat
Why Viking Therapeutics Inc. (VKTX) Went Down on Monday - MSN
These 10 Companies Led Monday’s Downturn - Insider Monkey
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today - Benzinga
Viking Therapeutics (NASDAQ:VKTX) Coverage Initiated by Analysts at Citigroup - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Given New $70.00 Price Target at Maxim Group - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Earns "Buy" Rating from B. Riley - MarketBeat
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today - Nasdaq
FY2027 Earnings Estimate for VKTX Issued By William Blair - MarketBeat
2 Stocks to Buy With Less Than $40 - Yahoo Finance
Viking Therapeutics Stock Price Forecast for 2025 - Markets.com
Viking Therapeutics started at neutral by Citi - MSN
Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):